Rictor regulates FBXW7-dependent c-Myc and cyclin E degradation in colorectal cancer cells

Biochemical and Biophysical Research Communications

Volumn 418, Issue 2, 2012, Pages 426-432

  Guo, Zheng ^a,c   Zhou, Yuning ^a   Evers, B Mark ^a,b   Wang, Qingding ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

C Myc; Colorectal cancer cells; Cyclin E; FBXW7; Rictor

Indexed keywords

CYCLIN E; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; MYC PROTEIN; PROTEIN CDC42; RAPAMYCIN INSENSITIVE COMPANION OF MTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; KNOCKOUT GENE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; UBIQUITINATION;

CARRIER PROTEINS; CELL CYCLE PROTEINS; COLORECTAL NEOPLASMS; CYCLIN E; F-BOX PROTEINS; HT29 CELLS; HUMANS; PROTEIN BIOSYNTHESIS; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-MYC; RNA, SMALL INTERFERING; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84862797119     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.01.054     Document Type: Article

References (28)

1. Fingar D.C., Blenis J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 2004, 23:3151-3171.
2. Guertin D.A., Sabatini D.M. Defining the role of mTOR in cancer. Cancer Cell 2007, 12:9-22.
3. Sarbassov D.D., Guertin D.A., Ali S.M., Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005, 307:1098-1101.
4. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96:857-868.
5. Diehl J.A., Cheng M., Roussel M.F., Sherr C.J. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 1998, 12:3499-3511.
6. Hartwell L.H., Mortimer R.K., Culotti J., Culotti M. Genetic control of the cell division cycle in yeast: V. Genetic analysis of cdc mutants. Genetics 1973, 74:267-286.
7. Feldman R.M., Correll C.C., Kaplan K.B., Deshaies R.J. A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p. Cell 1997, 91:221-230.
8. Welcker M., Clurman B.E. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat. Rev. Cancer 2008, 8:83-93.
9. Akhoondi S., Sun D., von der Lehr N., Apostolidou S., Klotz K., Maljukova A., Cepeda D., Fiegl H., Dafou D., Marth C., Mueller-Holzner E., Corcoran M., Dagnell M., Nejad S.Z., Nayer B.N., Zali M.R., Hansson J., Egyhazi S., Petersson F., Sangfelt P., Nordgren H., Grander D., Reed S.I., Widschwendter M., Sangfelt O., Spruck C. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res. 2007, 67:9006-9012.
10. Kimura T., Gotoh M., Nakamura Y., Arakawa H. HCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53. Cancer Sci. 2003, 94:431-436.
11. Grim J.E., Gustafson M.P., Hirata R.K., Hagar A.C., Swanger J., Welcker M., Hwang H.C., Ericsson J., Russell D.W., Clurman B.E. Isoform- and cell cycle-dependent substrate degradation by the Fbw7 ubiquitin ligase. J. Cell Biol. 2008, 181:913-920.
12. Sarbassov D.D., Ali S.M., Kim D.H., Guertin D.A., Latek R.R., Erdjument-Bromage H., Tempst P., Sabatini D.M. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 2004, 14:1296-1302.
13. McDonald P.C., Oloumi A., Mills J., Dobreva I., Maidan M., Gray V., Wederell E.D., Bally M.B., Foster L.J., Dedhar S. Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival. Cancer Res. 2008, 68:1618-1624.
14. Hagan G.N., Lin Y., Magnuson M.A., Avruch J., Czech M.P. A Rictor-Myo1c complex participates in dynamic cortical actin events in 3T3-L1 adipocytes. Mol. Cell. Biol. 2008, 28:4215-4226.
15. Zhang F., Zhang X., Li M., Chen P., Zhang B., Guo H., Cao W., Wei X., Cao X., Hao X., Zhang N. mTOR complex component Rictor interacts with PKCzeta and regulates cancer cell metastasis. Cancer Res. 2010, 70:9360-9370.
16. Gao D., Wan L., Inuzuka H., Berg A.H., Tseng A., Zhai B., Shaik S., Bennett E., Tron A.E., Gasser J.A., Lau A., Gygi S.P., Harper J.W., DeCaprio J.A., Toker A., Wei W. Rictor forms a complex with Cullin-1 to promote SGK1 ubiquitination and destruction. Mol. Cell 2010, 39:797-808.
17. Gao D., Wan L., Wei W. Phosphorylation of Rictor at Thr1135 impairs the Rictor/Cullin-1 complex to ubiquitinate SGK1. Protein Cell 2010, 1:881-885.
18. Liang J., Slingerland J.M. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell cycle 2003, 2:339-345.
19. Mullany L.K., Nelsen C.J., Hanse E.A., Goggin M.M., Anttila C.K., Peterson M., Bitterman P.B., Raghavan A., Crary G.S., Albrecht J.H. Akt-mediated liver growth promotes induction of cyclin E through a novel translational mechanism and a p21-mediated cell cycle arrest. J. Biol. Chem. 2007, 282:21244-21252.
20. Spruck C.H., Strohmaier H., Sangfelt O., Muller H.M., Hubalek M., Muller-Holzner E., Marth C., Widschwendter M., Reed S.I. HCDC4 gene mutations in endometrial cancer. Cancer Res. 2002, 62:4535-4539.
21. Kim D.H., Sarbassov D.D., Ali S.M., King J.E., Latek R.R., Erdjument-Bromage H., Tempst P., Sabatini D.M. MTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002, 110:163-175.
22. Mao J.H., Kim I.J., Wu D., Climent J., Kang H.C., DelRosario R., Balmain A. FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression. Science 2008, 321:1499-1502.
23. Ramana K.V., Tammali R., Srivastava S.K. Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cells. Mol. Cancer Ther. 2010, 9:813-824.
24. Chinni S.R., Sarkar F.H. Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells. Clin. Cancer Res. 2002, 8:1228-1236.
25. Choi H.J., Chung T.W., Kang S.K., Lee Y.C., Ko J.H., Kim J.G., Kim C.H. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression-transcriptional induction of p21 (WAF1) and p27 (kip1) by inhibition of PI-3K/AKT pathway. Glycobiology 2006, 16:573-583.
26. Myant K., Sansom O.J. Wnt/Myc interactions in intestinal cancer: partners in crime. Exp. Cell Res. 2011, 317:2725-2731.
27. Wright B., Brown S.J., Cole M.D. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells. Mol. Cell. Biol. 2010, 30:1411-1420.
28. Sutter T., Dansranjavin T., Lubinski J., Debniak T., Giannakudis J., Hoang-Vu C., Dralle H. Overexpression of cyclin E protein is closely related to the mutator phenotype of colorectal carcinoma. Int. J. Colorectal Dis. 2002, 17:374-380.